Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia
Clinical trial NCT05936489 · COMPLETED
Trial details
- NCT number
- NCT05936489
- Sponsor
- LENZ Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2023-10-03
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.